Rosuvastatin Gel With 1:1 Mixture of Platelet-rich Fibrin and Bone Graft in Mandibular Degree II Furcation Defects
Launched by GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE, BANGALORE · Feb 17, 2015
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
ABSTRACT Background: A wide range of regenerative materials have been tried in the treatment of furcation defects. Rosuvastatin (RSV) is a new synthetic, second-generation, sulfur-containing, hydrophilic statin, that stimulate bone formation in critical-size cortical bone defects adjacent to titanium implants, when administered locally in bone. Platelet-rich fibrin (PRF) is a platelet concentrate with sustained release of various growth factors, having regenerative potential to treat periodontal defects. Porous hydroxyapatite (HA) bone grafting material has clinically satisfactory response,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. the presence of buccal Class II furcation defects in endodontically vital, asymptomatic mandibular first and second molars with a radiolucency in the furcation area on an intraoral periapical radiograph with PD ± 5mm and horizontal PD ± 3mm after Phase I therapy (SRP)
- • 2. no history of antibiotic or periodontal therapy in the preceding 6 months.
- Exclusion Criteria:
- • 1. systemic illness known to affect the outcomes of periodontal therapy, such as diabetes mellitus, cardiac diseases, insufficient platelet count (\<200,000/mm3), or immunocompromised (e.g., HIV individuals) patients taking medications, such as corticosteroids or calcium channel blockers, which are known to interfere with periodontal wound healing
- • 2. individuals known or suspected allergy to the RSV group or allergic to medications
- • 3. systemic statin therapy
- • 4. pregnant or lactating women
- • 5. patients using tobacco in any form
- • 6. individuals with unacceptable oral hygiene (plaque index \>1.5). In addition, teeth with interproximal intrabony defects, gingival recession, endodontic (pulpal) involvement, or mobility of tooth ≥ Grade II were also excluded.
About Government Dental College And Research Institute, Bangalore
The Government Dental College and Research Institute, Bangalore, is a premier academic and research institution dedicated to advancing dental education and clinical practice. Renowned for its commitment to excellence, the institute engages in cutting-edge research and clinical trials aimed at improving oral health outcomes. With a focus on innovative treatment methodologies and evidence-based practices, the institute collaborates with various stakeholders to enhance dental care delivery and promote community health initiatives. Its distinguished faculty and state-of-the-art facilities foster a dynamic environment for the training of future dental professionals and the exploration of groundbreaking dental research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials